↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "L773:1879 0852 OR L773:0959 8049 ;pers:(Nilsson S)"

Search: L773:1879 0852 OR L773:0959 8049 > Nilsson S

Result 1-10 of 11

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Majumder, K, et al. (author) Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up study 2016 In: European journal of cancer (Oxford, England : 1990). - : Elsevier BV. - 1879-0852 .- 0959-8049. ; 65, s. 43-51 Journal article (peer-reviewed)
2.	Nilsson, S., et al. (author) A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer 2012 In: European Journal of Cancer. - Oxford : Elsevier. - 0959-8049 .- 1879-0852. ; 48:5, s. 678-686 Research review (peer-reviewed)abstract Purpose: To investigate the dose-response relationship and pain-relieving effect of radium-223, a highly bone-targeted alpha-pharmaceutical. Methods: One hundred patients with castration-resistant prostate cancer (CRPC) and painful bone metastases were randomized to a single intravenous dose of 5, 25, 50 or 100 kBq/kg radium-223. The primary end-point was pain index (visual analogue scale [VAS] and analgesic use), also used to classify patients as responders or non-responders. Results: A significant dose response for pain index was seen at week 2 (P = .035). At week 8 there were 40%, 63%, 56% and 71% pain responders (reduced pain and stable analgesic consumption) in the 5, 25, 50 and 100 kBq/kg groups, respectively. On the daily VAS, at week 8, pain decreased by a mean of -30, -31, -27 and -28 mm, respectively (P = .008, P = .0005, P = .002, and P < .0001) in these responders (post-hoc analysis). There was also a significant improvement in the brief pain inventory functional index for all dose-groups (P = .04, .01, .002 and .02, Wilcoxon signed rank test). Furthermore, a decrease in bone alkaline phosphatase in the highest dose-group was demonstrated (P = .0067). All doses were safe and well tolerated. Conclusion: Pain response was seen in up to 71% of the patients with a dose response observed 2 weeks after administration. The highly tolerable side-effect profile of radium-223 previously reported was confirmed. (C) 2012 Elsevier Ltd. All rights reserved.
3.	Parker, C, et al. (author) Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial 2017 In: European journal of cancer (Oxford, England : 1990). - : Elsevier BV. - 1879-0852 .- 0959-8049. ; 71, s. 1-6 Journal article (peer-reviewed)
4.	Parker, C., et al. (author) Effects of radium-223 dichloride (Ra-223) on health-related quality of life (QOL) outcomes in the phase 3 ALSYMPCA study in patients with castration-resistant prostate cancer (CRPC) and bone metastases 2013 In: European Journal of Cancer. - : Elsevier. - 0959-8049 .- 1879-0852. ; 49:Supplement 2, s. S689-S689, Meeting Abstract: 2878 Journal article (other academic/artistic)
5.	Klepp, O, et al. (author) Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer 1997 In: European journal of cancer (Oxford, England : 1990). - : Elsevier BV. - 0959-8049. ; 33:7, s. 1038-1044 Journal article (peer-reviewed)
6.	Majumder, K, et al. (author) The effect on prostate volume of anti-androgen versus total androgen blockade in prostate cancer patients - a randomized study 2015 In: EUROPEAN JOURNAL OF CANCER. - 0959-8049. ; 51, s. S485-S485 Conference paper (other academic/artistic)
7.	Strang, P, et al. (author) Mutant p53 protein as a predictor of survival in endometrial carcinoma 1996 In: European journal of cancer (Oxford, England : 1990). - : Elsevier BV. - 0959-8049. ; 32A:4, s. 598-602 Journal article (peer-reviewed)
8.	Berglund, Gunilla, et al. (author) Intention to test for prostate cancer 2005 In: European journal of cancer (Oxford, England : 1990). - : Elsevier BV. - 0959-8049. ; 41:7, s. 990-997 Journal article (peer-reviewed)
9.	Henriksson, R, et al. (author) Survival in renal cell carcinoma (RCC) - A randomised evaluation of tamoxifen versus interleukin-2, alpha-interferon (leukocyte) and tamoxifen 1997 In: EUROPEAN JOURNAL OF CANCER. - 0959-8049. ; 33, s. 152-152 Conference paper (other academic/artistic)
10.	Nordstrom, B, et al. (author) P53 protein as a predictor of survival in endometrial carcinomas 1995 In: EUROPEAN JOURNAL OF CANCER. - 0959-8049. ; 31A, s. 1173-1173 Conference paper (other academic/artistic)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 11

Refine your search

Type of publication: journal article (7); conference paper (3); research review (1)

Type of content: peer-reviewed (7); other academic/artistic (4)

Author/Editor: Nilsson, S. (11); Strang, P (4); Nordstrom, B (3); Johansson, H (2); Bergstrom, R (2); Tribukait, B (2); show more...; Parker, C (2); Brandberg, Y (2); Franzén, Lars (2); Majumder, K (2); Henriksson, R (1); Solberg, A. (1); Andersson, C (1); Nordin, Karin (1); Wersall, P. (1); Coleman, RE (1); Klepp, O (1); Bottomley, D. (1); O'Sullivan, JM (1); Dahl, O. (1); Wist, E (1); Zhan, L. (1); Bergenmar, M (1); Abramsson, L (1); Ullen, A (1); Berglund, Gunilla (1); Castellanos, E. (1); Tornblom, M. (1); Stierner, U (1); Hoskin, P. (1); Lennernas, B (1); Helsing, M (1); Edekling, T (1); Colleen, S (1); Olivier, P. (1); Zimmerman, R (1); Engman, K (1); Flodgren, P (1); Sartor, O. (1); Starkhammar, H (1); Heinrich, D (1); Vogelzang, NJ (1); Olsson, AM (1); Oldbring, J (1); Daehlin, L (1); Smaland, R (1); Raabe, N (1); CavallinStahl, E (1); Staffurth, J (1); Vasanthan, S (1); show less...

University: Karolinska Institutet (9); Umeå University (2); Uppsala University (2)

Language: English (11)

Research subject (UKÄ/SCB): Medical and Health Sciences (2); Natural sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view